大摩下调港交所(0388.HK)盈测反映市场交投弱
大摩发表报告指,港交所(00388.HK)7月成交量疲弱,现货市场交易额平均仅得690亿元,较上半年平均低30%。衍生产品于今年首六个月交投量一直大致稳定,至7月却见明显下跌,期货及期权交易额较上半年平均水平分别低20%及36%。互联互通部份表现亦疲弱。

基於以上表现,该行下调港交所2019年至2021年每股盈利预测各5%/2%/2%。该行重申,虽然目前周期性市场环境仍然艰难,但港交所作为受惠资金流入中国的地位无变。近期股价调整後估值吸引,对长期投资者而言是个机会,目标价维持于340港元,评级“增持”。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.